SNRPCP17

Across TCGA pan-cancer cohorts, SNRPCP17 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNRPCP17’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where SNRPCP17 RNA is repressed in tumor relative to normal tissue. In most cancer types SNRPCP17 is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.

LUSC, KICH, and THCA are the cancer types where SNRPCP17 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPCP17 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	III,IV	−0.430	.002	4	view →
KICH	Male	All	−0.128	.034	2	view →
THCA	Female	All	−0.051	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SNRPCP17–LUSC

Open the LUSC breakdown →